Commonwealth of Pennsylvania Public School Empls Retrmt SYS Buys 460 Shares of ICU Medical, Inc. $ICUI

Commonwealth of Pennsylvania Public School Empls Retrmt SYS increased its stake in shares of ICU Medical, Inc. (NASDAQ:ICUI) by 7.9% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 6,319 shares of the medical instruments supplier’s stock after acquiring an additional 460 shares during the quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS’s holdings in ICU Medical were worth $835,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors have also bought and sold shares of the stock. Envestnet Asset Management Inc. boosted its stake in shares of ICU Medical by 8.2% during the first quarter. Envestnet Asset Management Inc. now owns 20,269 shares of the medical instruments supplier’s stock valued at $2,815,000 after purchasing an additional 1,534 shares during the period. GSA Capital Partners LLP bought a new stake in ICU Medical during the 1st quarter valued at $614,000. Pacific Capital Partners Ltd purchased a new stake in ICU Medical during the 1st quarter valued at $12,845,000. Empirical Financial Services LLC d.b.a. Empirical Wealth Management bought a new stake in ICU Medical in the 1st quarter worth $895,000. Finally, PNC Financial Services Group Inc. increased its position in shares of ICU Medical by 23.6% in the first quarter. PNC Financial Services Group Inc. now owns 4,127 shares of the medical instruments supplier’s stock valued at $573,000 after acquiring an additional 788 shares during the period. 96.10% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

ICUI has been the subject of a number of analyst reports. Weiss Ratings reiterated a “sell (d-)” rating on shares of ICU Medical in a report on Wednesday, October 8th. Piper Sandler increased their price objective on ICU Medical from $153.00 to $172.00 and gave the stock an “overweight” rating in a report on Friday, November 7th. Wall Street Zen lowered ICU Medical from a “buy” rating to a “hold” rating in a research report on Saturday, November 15th. Raymond James Financial decreased their target price on ICU Medical from $187.00 to $180.00 and set a “strong-buy” rating for the company in a report on Friday, August 8th. Finally, KeyCorp lifted their price target on shares of ICU Medical from $173.00 to $175.00 and gave the company an “overweight” rating in a report on Friday, November 7th. One research analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $181.75.

Insider Activity at ICU Medical

In other ICU Medical news, VP Virginia Ruth Sanzone sold 930 shares of the firm’s stock in a transaction that occurred on Tuesday, November 11th. The shares were sold at an average price of $142.34, for a total transaction of $132,376.20. Following the completion of the transaction, the vice president owned 5,456 shares of the company’s stock, valued at approximately $776,607.04. This trade represents a 14.56% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Elisha W. Finney sold 1,285 shares of ICU Medical stock in a transaction that occurred on Tuesday, November 11th. The shares were sold at an average price of $140.42, for a total transaction of $180,439.70. Following the transaction, the director owned 3,995 shares of the company’s stock, valued at $560,977.90. The trade was a 24.34% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. 1.50% of the stock is currently owned by corporate insiders.

ICU Medical Stock Up 4.4%

Shares of NASDAQ:ICUI opened at $148.54 on Tuesday. The firm has a market capitalization of $3.67 billion, a P/E ratio of -97.72 and a beta of 0.83. The company has a debt-to-equity ratio of 0.63, a quick ratio of 1.17 and a current ratio of 2.44. The stock has a 50 day moving average price of $126.02 and a 200-day moving average price of $128.27. ICU Medical, Inc. has a 52-week low of $107.00 and a 52-week high of $175.51.

ICU Medical (NASDAQ:ICUI) last issued its quarterly earnings results on Thursday, November 6th. The medical instruments supplier reported $2.03 earnings per share for the quarter, topping the consensus estimate of $1.43 by $0.60. The company had revenue of $533.30 million for the quarter, compared to analysts’ expectations of $511.46 million. ICU Medical had a positive return on equity of 7.24% and a negative net margin of 1.56%.The firm’s revenue for the quarter was down 8.9% on a year-over-year basis. During the same period in the prior year, the firm earned $1.59 earnings per share. ICU Medical has set its FY 2025 guidance at 7.350-7.650 EPS. As a group, equities research analysts anticipate that ICU Medical, Inc. will post 4.11 EPS for the current fiscal year.

ICU Medical Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.